Posted by Michael Wonder on 01 Jan 2025
Sotatercept approved to treat adult patients with pulmonary arterial hypertension
27 December 2024 - The MHRA has approved the medicine sotatercept (Winrevair) to treat pulmonary arterial hypertension.
Sotatercept is used, in combination with other medicines to treat PAH, in adults with moderate or marked limitations of physical activity, to improve exercise capacity.
